REGULATION OF CELL PROLIFERATION BY TYROSINE PROTEINKINASES RECEPTORS AND THEIR ROLE IN TRIGGERING DIFFERENT TYPES OF CANCERS
Authors/Creators
- 1. student, Faculty of General Medicine, SUMPh "Nicolae Testemitanu" Chisinau, Republic of Moldova
- 2. PhD, university lector, State University of Medicine and Pharmacy "Nicolae Testemitanu" Chisinau, Republic of Moldova
Description
Receptor tyrosine proteinkinases (RTKs) are transmembrane proteins that possess kinase activity catalyzing the transfer of phosphate groups from ATP to tyrosine residues in protein substrates. RTKs play an important role in the control of most fundamental cellular processes such as proliferation, differentiation, cell metabolism and survival, cell migration and cell cycle control. Tyrosine proteinkinase receptors comprise 58 different types in humans that are classified into 20 families according to structure and ligand. Mutations in RTKs and aberrant activation of their intracellular signalling pathways lead to the triggering of different types of cancers. In human cancers, four fundamental mechanisms have been found to lead to constitutive activation of RTKs: genomic amplification, gain-of-function mutations, chromosomal rearrangements and autocrine activation. Thus, aberrant activation of receptor tyrosine protein kinase is a potential therapeutic target. In recent decades, several drugs, such as tyrosine kinase inhibitors, have been developed and clinically evaluated to improve the survival of cancer patients.